Advanced or Unresectable Locally Advanced Bone and Soft Tissue Sarcoma Clinical Trials in Shanghai, Shanghai Municipality

A Single-arm, Open-label, Single-center Prospective Study of Fruquintinib Combined With Envafolimab in the Treatment of Advanced or Unresectable Locally Advanced Bone and Soft Tissue Sarcoma